Screening analysis of proteolytic enzymes and their inhibitors in the leaflets of epoxy-treated bioprosthetic heart valves explanted due to dysfunction
Bioprosthetic heart valves (BHVs) are known for their lower thrombogenicity rates and excellent hemodynamic parameters similar to native valves. However, the lifespan of these medical devices is limited to 15 years due to the structural valve degeneration. One of the mechanisms underlying functional impairment and calcification of BHVs includes proteolytic degradation of biomaterials. However, proteases found in xenogeneic BHVs tissue remain poorly studied. In this study using the dot blot assay, we have performed a screening analysis of proteolytic enzymes and their inhibitors in the leaflets of five BHVs explanted due to their dysfunction. Five aortic valves (AVs) explanted due to calcific aortic valve disease were studied as a comparison group. The results of the study have demonstrated that at least 17 proteases and 19 of their inhibitors can be found in BHVs. In the AVs 20 proteases and 21 their inhibitors were identified. Small quantitative differences were noted between proteomic profiles of the BHVs and AVs. Matrix metalloproteinases (MMPs) were expressed in BHVs and AVs at comparable levels, but the level of tissue inhibitors of metalloproteinases-1/-2 and RECK protein in implant tissues was lower than in natural valves. Probably, excessive activity of MMPs cannot be counterbalanced by their inhibitors in BHVs and therefore MMPs can degrade prosthetic biomaterial. Moreover, the detection of a wide range of proteolytic enzymes and their inhibitors in the degenerated BHVs suggests the existence of several pathophysiological pathways that can lead to structural valve degeneration.
Kostyunin A.E., Glushkova T.V., Shishkova D.K., Markova V.E., Ovcharenko E.A. (2022) Screening analysis of proteolytic enzymes and their inhibitors in the leaflets of epoxy-treated bioprosthetic heart valves explanted due to dysfunction. Biomeditsinskaya Khimiya, 68(1), 68-75.
Kostyunin A.E. et al. Screening analysis of proteolytic enzymes and their inhibitors in the leaflets of epoxy-treated bioprosthetic heart valves explanted due to dysfunction // Biomeditsinskaya Khimiya. - 2022. - V. 68. -N 1. - P. 68-75.
Kostyunin A.E. et al., "Screening analysis of proteolytic enzymes and their inhibitors in the leaflets of epoxy-treated bioprosthetic heart valves explanted due to dysfunction." Biomeditsinskaya Khimiya 68.1 (2022): 68-75.
Kostyunin, A. E., Glushkova, T. V., Shishkova, D. K., Markova, V. E., Ovcharenko, E. A. (2022). Screening analysis of proteolytic enzymes and their inhibitors in the leaflets of epoxy-treated bioprosthetic heart valves explanted due to dysfunction. Biomeditsinskaya Khimiya, 68(1), 68-75.
Bax J.J., Delgado V. (2017) Bioprosthetic heart valves, thrombosis, anticoagulation, and imaging surveillance. JACC: Cardiovascular Interventions, 10(4), 388-390. CrossRef Scholar google search
Head S.J., Çelik M., Kappetein A.P. (2017) Mechanical versus bioprosthetic aortic valve replacement. Eur. Heart J., 38(28), 2183-2191. CrossRef Scholar google search
Bourguignon T., Espitalier F., Pantaleon C., Vermes E., El-Arid J.M., Loardi C., Karam E., Candolfi P., Ivanes F., Aupart M. (2018) Bioprosthetic mitral valve replacement in patients aged 65 years or younger: long-term outcomes with the Carpentier-Edwards PERIMOUNT pericardial valve. Eur. J. Cardiothorac. Surg., 54(2), 302-309. CrossRef Scholar google search
Foroutan F., Guyatt G.H., O'Brien K., Bain E., Stein M., Bhagra S., Sit D., Kamran R., Chang Y., Devji T., Mir H., Manja V., Schofield T., Siemieniuk R.A., Agoritsas T., Bagur R., Otto C.M., Vandvik P.O. (2016) Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies. The BMJ, 354, i5065. CrossRef Scholar google search
Capodanno D., Petronio A.S., Prendergast B., Eltchaninoff H., Vahanian A., Modine T., Lancellotti P., Sondergaard L., Ludman P.F., Tamburino C., Piazza N., Hancock J., Mehilli J., Byrne R.A., Baumbach A., Kappetein A.P., Windecker S., Bax J., Haude M. (2017) Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J., 38(45), 3382-3390. CrossRef Scholar google search
Dvir D., Bourguignon T., Otto C.M., Hahn R.T., Rosenhek R., Webb J.G., Treede H., Sarano M.E., Feldman T., Wijeysundera H.C., Topilsky Y., Aupart M., Reardon M.J., Mackensen G.B., Szeto W.Y., Kornowski R., Gammie J.S., Yoganathan A.P., Arbel Y., Borger M.A., Simonato M., Reisman M., Makkar R.R., Abizaid A., McCabe J.M., Dahle G., Aldea G.S., Leipsic J., Pibarot P., Moat N.E., Mack M.J., Kappetein A.P., Leon M.B. (2018) Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves. Circulation, 137(4), 388-399. CrossRef Scholar google search
Otto C.M., Nishimura R.A., Bonow R.O., Carabello B.A., Erwin J.P. 3rd, Gentile F., Jneid H., Krieger E.V., Mack M., McLeod C., O'Gara P.T., Rigolin V.H., Sundt T.M. 3rd, Thompson A., Toly C. (2021) 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Joint Committee on clinical practice guidelines. Circulation, 143(5), e72-e227. CrossRef Scholar google search
Otto C.M., Nishimura R.A., Bonow R.O., Carabello B.A., Erwin J.P. 3rd, Gentile F., Jneid H., Krieger E.V., Mack M., McLeod C., O'Gara P.T., Rigolin V.H., Sundt T.M. 3rd, Thompson A., Toly C. (2021) 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Joint Committee on clinical practice guidelines. J. Am. Coll. Cardiol., 77(4), e25-e197. CrossRef Scholar google search
Rezvova M.A., Kudryavceva Yu.A. (2018) Modern approaches to protein chemical modification in biological tissue, consequences and application. Bioorganicheskaya Khimiya, 44(1), 1-16. CrossRef Scholar google search
Isenburg J.C., Simionescu D.T., Vyavahare N.R. (2004) Elastin stabilization in cardiovascular implants: improved resistance to enzymatic degradation by treatment with tannic acid. Biomaterials, 25(16), 3293-3302. CrossRef Scholar google search
Zhuravleva I.Y., Karpova E.V., Oparina L.A., Poveschenko O.V., Surovtseva M.A., Titov A.T., Ksenofontov A.L., Vasilieva M.B., Kuznetsova E.V., Bogachev-Prokophiev A.V., Trofimov B.A. (2021) Cross-linking method using pentaepoxide for improving bovine and porcine bioprosthetic pericardia: a multiparametric assessment study. Materials Science and Engineering C: Materials for Biological Applications, 118, 111473. CrossRef Scholar google search
Shetty R., Pibarot P., Audet A., Janvier R., Dagenais F., Perron J., Couture C., Voisine P., Despres J.P., Mathieu P. (2009) Lipid-mediated inflammation and degeneration of bioprosthetic heart valves. Eur. J. Clin. Invest., 39(6), 471-480. CrossRef Scholar google search
Kostyunin A.E., Glushkova T.V. (2020) Expression of matrix metalloproteinases 1, 2, 9, 12 in xenogenic tissues of epoxy-crosslinked bioprosthetic heart valves explanted due to dysfunction. Russian Journal of Cardiology, 25(10), 49-55. CrossRef Scholar google search
Sakaue T., Nakaoka H., Shikata F., Aono J., Kurata M., Uetani T., Hamaguchi M., Kojima A., Uchita S., Yasugi T., Higashi H., Suzuki J., Ikeda S., Higaki J., Higashiyama S., Izutani H. (2018) Biochemical and histological evidence of deteriorated bioprosthetic valve leaflets: the accumulation of fibrinogen and plasminogen. Biology Open, 7(8), pii:bio034009. CrossRef Scholar google search
Simionescu A., Simionescu D.T., Deac R.F. (1996) Matrix metalloproteinases in the pathology of natural and bioprosthetic cardiac valves. Cardiovascular Pathology, 5(6), 323-332. CrossRef Scholar google search
Kostyunin A.E., Glushkova T.V., Bogdanov L.A., Ovcharenko E.A. (2021) Expression of tissue inhibitors of metalloproteinases type 1 and type 2 in the leaflets of explanted bioprosthetic heart valves: a new pathogenetic parallel between structural valve degeneration and calcific aortic stenosis. Russian Journal of Transplantology and Artificial Organs, 23(3), 115-121. CrossRef Scholar google search
Lindman B.R., Clavel M.A., Mathieu P., Iung B., Lancellotti P., Otto C.M., Pibarot P. (2016) Calcific aortic stenosis. Nature Reviews Disease Primers, 2, 16006. CrossRef Scholar google search
Miller J.D., Weiss R.M., Heistad D.D. (2011) Calcific aortic valve stenosis: methods, models, and mechanisms. Circulation Res., 108(11), 1392-1412. CrossRef Scholar google search
Chang C.K., Hung W.C., Chang H.C. (2008) The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo. J. Cell. Mol. Med., 12(6B), 2781-2789. CrossRef Scholar google search
Arpino V., Brock M., Gill S.E. (2015) The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biology, 44-46, 247-254. CrossRef Scholar google search
Nair V., Law K.B., Li A.Y., Phillips K.R., David T.E., Butany J. (2012) Characterizing the inflammatory reaction in explanted Medtronic Freestyle stentless porcine aortic bioprosthesis over a 6-year period. Cardiovascular Pathology, 21(3), 158-168. CrossRef Scholar google search
Kostyunin A.E., Yuzhalin A.E., Ovcharenko E.A., Kutikhin A.G. (2019) Development of calcific aortic valve disease: Do we know enough for new clinical trials? J. Mol. Cell. Cardiol., 132, 189-209. CrossRef Scholar google search
Shen M., Carpentier S.M., Berrebi A.J., Chen L., Martinet B., Carpentier A. (2001) Protein adsorption of calcified and noncalcified valvular bioprostheses after human implantation. Ann. Thorac. Surg., 71(5 Suppl), S406-S407. CrossRef Scholar google search
